Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines-Reference-Cited by-同舟云学术

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines

Published:2017-08-31 Issue:3 Volume:15 Page:199-209
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Wang Hee Ryung¹,Bahk Won-Myong¹,Seo Jeong Seok²,Woo Young Sup¹,Park Young-Min³,Jeong Jong-Hyun⁴,Kim Won⁵⁶,Shim Se-Hoon⁷,Lee Jung Goo⁸⁹¹⁰,Jon Duk-In¹¹,Min Kyung Joon¹²

Affiliation:

1. Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea

2. Department of Psychiatry, Konkuk University School of Medicine, Chungju, Korea

3. Department of Psychiatry, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea

4. Department of Psychiatry, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea

5. Department of Psychiatry, Inje University Seoul Paik Hospital, Inje University School of Medicine, Seoul, Korea

6. Stress Research Institute, Inje University, Seoul, Korea

7. Department of Psychiatry, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea

8. Department of Psychiatry, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea

9. Paik Institute for Clinical Research, Inje University, Busan, Korea

10. Department of Health Science and Technology, Graduate School of Inje University, Busan, Korea

11. Department of Psychiatry, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea

12. Department of Psychiatry, Chung-Ang University College of Medicine, Seoul, Korea

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2017/015/cpn015-03-01.pdf

Reference27 articles.

1. Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study

2. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed

3. Vilazodone: A Review in Major Depressive Disorder in Adults

4. Desvenlafaxine for the Acute Treatment of Depression: A Systematic Review and Meta-analysis

5. Zadka, Ł, Dziwota, E, and Olajossy, M (2016). Levomilnacipran—a successor of milnacipran with a higher noradrenergic selectivity. Acta Pol Pharm. 73, 285-289.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical use of mood stabilizers beyond treatment for bipolar disorder: The REAP-MS study;Asian Journal of Psychiatry;2023-07

2. Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study;Pharmaceutics;2022-12-02

3. Botulinum Toxin in Facial Aesthetics Affects the Emotion Process: A Meta-analysis of Randomized Controlled Trials;Clinical Psychopharmacology and Neuroscience;2022-11-30

4. Prescribing behavior of antidepressants for depressive disorders: A systematic review;Frontiers in Psychiatry;2022-09-09

5. Quality of clinical practice guidelines for inadequate response to first-line treatment for depression according to AGREE II checklist and comparison of recommendations: a systematic review;BMJ Open;2022-04